Alnylam Pharmaceuticals
Peggy T. has extensive experience in alliance management and leadership within the biotechnology sector, currently serving as Vice President and Head of Alliance Management at Alnylam Pharmaceuticals since January 2020. Previously held roles include General Manager of Neuroscience at BioLegend, where responsibilities encompassed strategic planning and operational management, and Director of Antibody Products at Covance, overseeing business strategy and team development. Peggy has a strong background in research and development, demonstrated through leadership positions at Signet Laboratories and Sequitur, where significant contributions included guiding companies through acquisitions and driving innovation in antibody production. Peggy holds a ScD in Cell Biology from the Harvard T.H. Chan School of Public Health and a degree from Trinity College-Hartford.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.